期刊文献+

癌痛消颗粒对移植性肝癌模型大鼠肝癌组织miRNAs表达的影响 被引量:5

The Effect on miRNAs of Replant Liver Cancer Rats Treated by Aitongxiao Granule
原文传递
导出
摘要 目的用大鼠Walker-256移植性肝癌模型研究癌痛消颗粒对大鼠肝癌miRNAs的调节作用,以探讨癌痛消颗粒抗肝癌的可能机制。方法将60只大鼠移植性肝癌模型随机分为5组,即癌痛消颗粒高剂量组(A组)、中剂量组(B组)、低剂量组(C组)、5-Fu组(D组)、生理盐水组(E组),于造模后第8天对癌痛消治疗组及生理盐水组灌胃给药,5-Fu组腹腔注射给药,连续用药14 d后停药24 h,处死大鼠,取出瘤块,用实时定量聚合酶链反应(qRT-PCR)技术观察肝癌特定miRNAs(miR-199a-3p、miR-199a-5p、miR-18)表达水平。另设正常饲养组(F组)大鼠10只,不进行造模及给药,供实验结束时作空白对照用。结果造模组与空白对照组比较miR-18有更高水平的表达,miR-199a-3p,miR-199a-5p表达水平降低;造模各组(A、B、C、D组)药物干预后与生理盐水组(E组)比较肝癌组织miR-18表达水平降低,miR-199a-3p,miR-199a-5p表达水平升高(P<0.01);和E组比较,A、B、C、D组均可明显调节miRNAs水平,癌痛消中剂量组比5-FU组更为明显(P<0.01)。结论口服癌痛消颗粒对大鼠移植性肝癌组织的miRNAs表达具有一定的调控作用,提示癌痛消的抗癌机制可能与调控肝细胞癌发生和发展相关的miRNAs水平有关。 OBJECTIVE To explore the effect of Aitongxiao granule (traditional Chinese medicines) therapy on miRNAs of re- plant liver cancer rats. METHODS The 60 replant liver cancer rats were randomly divided into high dose ( A), middle dose ( B ), lower dose(C), 5-Fu(D) ,distilled water(E) groups. After 14 days of experimental treatment, the expressions of miR-199a-3p,miR- 199a-5p ,miR-18 in liver cancer tissues were detected with qRT-PCR. RESULTS Before experimental treatment,in comparison with E group, the level of miR-I 8 was higher but level of miR-199a-3p, miR-199a-5p were lower in A,B,C ,D groups (P 〈 0.01 ). After 14 days of experimental treatment, in comparison with E group, the level of miR-18 was lower but level of miR-199a-3p, miR-199a-5p were higher in A ,B ,C ,D groups( P 〈 0.01 ). The more significant differences were found in B group than that in D group. CONCLU- SION The Aitongxiao granule has the regulative effects on miRNAs of replant liver cancer rats . Its therapeutical effects relate to the miRNAs expressions of liver cellular cancer development .
作者 黄峰 韦艾凌
出处 《中国药学杂志》 CAS CSCD 北大核心 2013年第20期1740-1743,共4页 Chinese Pharmaceutical Journal
基金 广西壮族自治区中医药管理局资助课题(GZKZ09-21)
关键词 癌痛消颗粒 miR-199a-3p miR-199a-5p miR-18 Aitongxiao granule miR-199a-3p miR-199a-5p miR-18
  • 相关文献

参考文献5

  • 1WEI L C,WEI A L. The experimental study on the expression of MVD VEGF of hepatoma in rats with the Aitongxiao granule.辽宁中医药大学学报,2008,10(8):159-160.
  • 2SHIMADA K,SAKAMOTO Y,ESAKI M,et al. Analysis of prognostic factors affecting survival after initial recurrence and treatment efficacy for recurrence in patients undergoing potentially curative hepatectomy for hepatocellular carcinoma.Ann Surg Oncol,2007,14(8):2337-2347.
  • 3MURADAMI Y,YASUDA T, SAIGO K, et al. Comprehensive analysis of microRNA expression patterns in hepatocellular carcinoma and non-tumorous tissues.Oncogene,2006, 25: 2537-2545.
  • 4WEI A L,TANG J .The efficacy analysis of the liver blood stasis toxin knot and deficiency in primary hepatic carcinoma with Aitongxiao granule. 辽宁中医药大学学报, 2007, 34(5):570-572.
  • 5WEI L C, WEI A L. The study on the rat hepatoma cell apoptosis and Bcl-2 expression with Aitongxiao granule.江西中医药大学学报,2008,20(3):82-84.

同被引文献79

引证文献5

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部